183 related articles for article (PubMed ID: 22526649)
21. Simultaneous and rapid determination of 12 tyrosine kinase inhibitors by LC-MS/MS in human plasma: Application to therapeutic drug monitoring in patients with non-small cell lung cancer.
Zhou L; Wang S; Chen M; Huang S; Zhang M; Bao W; Bao A; Zhang P; Guo H; Liu Z; Xie G; Gao J; Wu Z; Lou Y; Fan G
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jun; 1175():122752. PubMed ID: 33991955
[TBL] [Abstract][Full Text] [Related]
22. Novel high-performance liquid chromatography-tandem mass spectrometry method for simultaneous quantification of BCR-ABL and Bruton's tyrosine kinase inhibitors and their three active metabolites in human plasma.
Mukai Y; Yoshida T; Kondo T; Inotsume N; Toda T
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Jan; 1137():121928. PubMed ID: 31877431
[TBL] [Abstract][Full Text] [Related]
23. A rapid liquid chromatography-tandem mass spectrometry analysis of whole blood sirolimus using turbulent flow technology for online extraction.
Wang S; Miller A
Clin Chem Lab Med; 2008; 46(11):1631-4. PubMed ID: 18842108
[TBL] [Abstract][Full Text] [Related]
24. Simultaneous measurement of imatinib, nilotinib and dasatinib in dried blood spot by ultra high performance liquid chromatography tandem mass spectrometry.
Kralj E; Trontelj J; Pajič T; Kristl A
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Aug; 903():150-6. PubMed ID: 22857863
[TBL] [Abstract][Full Text] [Related]
25. Development and validation of a sensitive LC-MS/MS method for simultaneous determination of eight tyrosine kinase inhibitors and its application in mice pharmacokinetic studies.
He Y; Zhou L; Gao S; Yin T; Tu Y; Rayford R; Wang X; Hu M
J Pharm Biomed Anal; 2018 Jan; 148():65-72. PubMed ID: 28965046
[TBL] [Abstract][Full Text] [Related]
26. Measurement of the direct oral anticoagulants apixaban, dabigatran, edoxaban, and rivaroxaban in human plasma using turbulent flow liquid chromatography with high-resolution mass spectrometry.
Gous T; Couchman L; Patel JP; Paradzai C; Arya R; Flanagan RJ
Ther Drug Monit; 2014 Oct; 36(5):597-605. PubMed ID: 24695356
[TBL] [Abstract][Full Text] [Related]
27. High throughput routine determination of 17 tyrosine kinase inhibitors by LC-MS/MS.
Merienne C; Rousset M; Ducint D; Castaing N; Titier K; Molimard M; Bouchet S
J Pharm Biomed Anal; 2018 Feb; 150():112-120. PubMed ID: 29220734
[TBL] [Abstract][Full Text] [Related]
28. Simultaneous determination of 11 oral targeted antineoplastic drugs and 2 active metabolites by LC-MS/MS in human plasma and its application to therapeutic drug monitoring in cancer patients.
Zhao J; Yan D; Li Y; Xu X; Li F; Zhang S; Jin J; Qiu F
J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Apr; 1237():124100. PubMed ID: 38547701
[TBL] [Abstract][Full Text] [Related]
29. Simple methodology for the therapeutic drug monitoring of the tyrosine kinase inhibitors dasatinib and imatinib.
Birch M; Morgan PE; Handley S; Ho A; Ireland R; Flanagan RJ
Biomed Chromatogr; 2013 Mar; 27(3):335-42. PubMed ID: 22886846
[TBL] [Abstract][Full Text] [Related]
30. Development of a high-performance liquid chromatographic-mass spectrometric method for the determination of cellular levels of the tyrosine kinase inhibitors lapatinib and dasatinib.
Roche S; McMahon G; Clynes M; O'Connor R
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Dec; 877(31):3982-90. PubMed ID: 19854117
[TBL] [Abstract][Full Text] [Related]
31. A fast and simple assay for busulfan in serum or plasma by liquid chromatography-tandem mass spectrometry using turbulent flow online extraction technology.
Bunch DR; Heideloff C; Ritchie JC; Wang S
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Dec; 878(31):3255-8. PubMed ID: 21030324
[TBL] [Abstract][Full Text] [Related]
32. Ultra-fast cyclosporin A quantitation in whole blood by Laser Diode Thermal Desorption-tandem mass spectrometry; comparison with High Performance Liquid Chromatography-tandem mass spectrometry.
Jourdil JF; Picard P; Meunier C; Auger S; Stanke-Labesque F
Anal Chim Acta; 2013 Dec; 805():80-6. PubMed ID: 24296146
[TBL] [Abstract][Full Text] [Related]
33. Development and clinical validation of a simple and fast UPLC-ESI-MS/MS method for simultaneous quantification of nine kinase inhibitors and two antiandrogen drugs in human plasma: Interest for their therapeutic drug monitoring.
Llopis B; Robidou P; Tissot N; Pinna B; Gougis P; Aubart FC; Campedel L; Abbar B; Weil DR; Uzunov M; Gligorov J; Salem JE; Funck-Brentano C; Zahr N
J Pharm Biomed Anal; 2021 Apr; 197():113968. PubMed ID: 33618135
[TBL] [Abstract][Full Text] [Related]
34. Liquid chromatography-tandem mass spectrometric assay for therapeutic drug monitoring of the tyrosine kinase inhibitor pazopanib in human plasma.
Sparidans RW; Ahmed TT; Muilwijk EW; Welzen ME; Schellens JH; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Sep; 905():137-40. PubMed ID: 22917595
[TBL] [Abstract][Full Text] [Related]
35. The development and validation of a turbulent flow-liquid chromatography-tandem mass spectrometric method for the simultaneous quantification of citalopram, sertraline, bupropion and hydroxybupropion in serum.
Petrides AK; Moskowitz J; Johnson-Davis KL; Jannetto PJ; Langman LJ; Clarke W; Marzinke MA
Clin Biochem; 2014 Oct; 47(15):73-9. PubMed ID: 25087976
[TBL] [Abstract][Full Text] [Related]
36. Determination of iohexol in human serum by a semi-automated liquid chromatography tandem mass spectrometry method.
Vicente FB; Vespa GK; Carrara F; Gaspari F; Haymond S
Clin Biochem; 2015 Jul; 48(10-11):679-85. PubMed ID: 25835151
[TBL] [Abstract][Full Text] [Related]
37. A liquid chromatography-tandem mass spectrometry method for simultaneous quantification of thirty-nine tyrosine kinase inhibitors in human plasma.
Guo ZX; Wu YE; Shi HY; van den Anker J; Liang P; Zheng Y; Zhao XW; Feng R; Zhao W
J Pharm Biomed Anal; 2023 Feb; 224():115159. PubMed ID: 36442459
[TBL] [Abstract][Full Text] [Related]
38. A method to quantify several tyrosine kinase inhibitors in plasma by micellar liquid chromatography and validation according to the European Medicines Agency guidelines.
Garrido-Cano I; García-García A; Peris-Vicente J; Ochoa-Aranda E; Esteve-Romero J
Talanta; 2015 Nov; 144():1287-95. PubMed ID: 26452960
[TBL] [Abstract][Full Text] [Related]
39. Simultaneous quantification of erlotinib, gefitinib, and imatinib in human plasma by liquid chromatography tandem mass spectrometry.
Chahbouni A; den Burger JC; Vos RM; Sinjewel A; Wilhelm AJ
Ther Drug Monit; 2009 Dec; 31(6):683-7. PubMed ID: 19865001
[TBL] [Abstract][Full Text] [Related]
40. Quantification of eight hematological tyrosine kinase inhibitors in both plasma and whole blood by a validated LC-MS/MS method.
Verougstraete N; Stove V; Verstraete AG; Stove C
Talanta; 2021 May; 226():122140. PubMed ID: 33676691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
